Alisha Jamil, MD
Cardiology
Accepting new patients
Sees patients age 18 and up
Penn Cardiology Penn Presbyterian
View 1 additional location
Penn Medicine Provider

About me

Education and training

  • Medical School: University of Pennsylvania Health System
  • Residency: University of Pennsylvania Health System
  • Fellowship: Temple University Hospital

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Jamil is a Penn Medicine physician. In New Jersey, providers are affiliated with Penn Medicine through Clinical Health Care Associates of New Jersey or Princeton Healthcare Affiliated Physicians, PC.

Qualifications and experience

Treatments and Conditions

My research

Jamil, A., Bhatia-Patel, S., Schneider, P., Fabrizio, C., Rakita, V., Boucher, T., Yanagida, R., Toyoda, Y., & Hamad, E.A. Cangrelor With Heparin For Left Ventricular Assist Device Implantation In The Setting Of Heparin Induced Thrombocytopenia. , Journal of Cardiac Failure., 30(1): 2024,151


Decker BM, Turco A, Xu J, Terman SW, Kosaraju N, Jamil A, Davis KA, Litt B, Ellis CA, Khankhanian P, Hill CE. Development of a natural language processing algorithm to extract seizure types and frequencies from the electronic health record , Seizure: 2022,48-51


Liang LW, Jamil A, Mazurek JA, Urgo KA, Wald J, Birati EY, Han Y. Right Ventricular Global Longitudinal Strain as a Predictor of Acute and Early Right Heart Failure Post Left Ventricular Assist Device Implantation , ASAIO J, 68(3): 2022,333-339


Agarwalla, A., Bhatt, B., Ibe, O., Mukunda, N., Jarrah A., Jamil, A., Ambrose, M., Karpenshif, Y. Need to Curriculum: Developing and Implementing a Resident Driven Cardiac Emergencies Curriculum. , Northeast Group for Educational Affairs Virtual Conference: 2022


Jamil, A., Owens, A.T., Holzhauser, L., Genuardi, M.V., Goldberg, L.R., Domenico, C., Reza, N. Use Of Sacubitril/valsartan In Patients With Cardiogenic Shock On Inotropic Support , Journal of Cardiac Failure. , 28(5): 2022,S16-S17


Jamil A, Johnston-Cox H, Pugliese S, Nathan AS, Fiorilli P, Khandhar S, Weinberg MD, Giri J, Kobayashi T. Current interventional therapies in acute pulmonary embolism , Prog Cardiovasc Dis, 69: 2021,54-61


Jamil A, Levinson N, Gelfand M, Hill CE, Khankhanian P, Davis KA. Efficacy and Tolerability of Clobazam in Adults With Drug-Refractory Epilepsy , Neurol Clin Pract, 11(5): 2021,e669-e676


Jamil, A., Levinson, N., Khankhanian, P., Hill, C., Davis, K.A. Efficacy and tolerability of clobazam in adults with drug-refractory epilepsy. , Neurol Clin Pract, 11(5): 2021,e669-e676


Thompson EW, Kamesh Iyer S, Solomon MP, Li Z, Zhang Q, Piechnik S, Werys K, Swago S, Moon BF, Rodgers ZB, Hall A, Kumar R, Reza N, Kim J, Jamil A, Desjardins B, Litt H, Owens A, Witschey WRT, Han Y. Endogenous T1ρ cardiovascular magnetic resonance in hypertrophic cardiomyopathy , J Cardiovasc Magn Reson, 23(1): 2021,120


Reza, N., Mahmud, N., Denduluri, S., Jamil, A., Owens, A.T., Goldberg, L.R., Adusumalli, S. Initiation and Continuation of Guideline Directed Medical Therapy in Patients with Incident Heart Failure in a Large Integrated Health System. , Heart Failure Society of America Annual Scientific Meeting : 2021